Board of Directors

Executive Committee:

  • Paul Petrelli, President & General Manager, Jazz Pharmaceuticals (Chair)
  • Gordon McCauley, President and CEO, adMare Innovations (Vice Chair)
  • Kevin Leshuk, General Manager, Celgene Inc. (Treasurer)
  • Roberto Bellini, President & CEO, Bellus Health (Member at Large)
  • Andrew Casey, President & CEO, BIOTECanada (Secretary)


  • Chris Aiello, Franchise Head, Sanofi-Genzyme
  • Norma Biln, CEO, Augurex
  • Kennet Brysting,VP & General Manager, Gilead Canada
  • Neal Carter, President & Founder, Okanagan Specialty Fruits
  • Natalie Dakers, President & CEO, Accel-Rx Health Sciences
  • John Helou, President & CEO, Pfizer Canada
  • Alok Kanti, General Manager, Bayer Canada
  • A.J. (Sandy) Marshall, Chairman, Bioindustrial Innovation Canada
  • John Norman, Partner, Gowling WLG (Canada) LLP
  • Sanj Singh, President & CEO, Temple Therapeutics B.V.
  • Jamie Stiff, Managing Director, Genesys Capital
  • Oliver Technow, CEO, BioVectra Inc.
  • Shermaine Tilley, Managing Partner, CTI Life Sciences Fund
  • Dan Wattier, CEO, ImStar Therapeutics